Synthomer plc

LSE:SYNT Stock Report

Market Cap: UK£112.0m

Synthomer Balance Sheet Health

Financial Health criteria checks 2/6

Synthomer has a total shareholder equity of £996.6M and total debt of £904.7M, which brings its debt-to-equity ratio to 90.8%. Its total assets and total liabilities are £2.5B and £1.5B respectively.

Key information

90.78%

Debt to equity ratio

UK£904.70m

Debt

Interest coverage ration/a
CashUK£266.40m
EquityUK£996.60m
Total liabilitiesUK£1.46b
Total assetsUK£2.45b

Recent financial health updates

Recent updates

UK£1.57: That's What Analysts Think Synthomer plc (LON:SYNT) Is Worth After Its Latest Results

Aug 09
UK£1.57: That's What Analysts Think Synthomer plc (LON:SYNT) Is Worth After Its Latest Results
User avatar

Chemical Realignment And Adhesives Expansion Will Build A Resilient Future

Shift to high-margin specialty chemicals and divestment of non-core operations are expected to enhance profitability.

Investors Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues

Jan 08
Investors Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues

Synthomer plc (LON:SYNT) Screens Well But There Might Be A Catch

Oct 05
Synthomer plc (LON:SYNT) Screens Well But There Might Be A Catch

Calculating The Intrinsic Value Of Synthomer plc (LON:SYNT)

Aug 03
Calculating The Intrinsic Value Of Synthomer plc (LON:SYNT)

Synthomer (LON:SYNT) Has Debt But No Earnings; Should You Worry?

Jun 18
Synthomer (LON:SYNT) Has Debt But No Earnings; Should You Worry?

Investors Still Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues Despite 27% Price Jump

May 25
Investors Still Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues Despite 27% Price Jump

Is Synthomer plc (LON:SYNT) Expensive For A Reason? A Look At Its Intrinsic Value

Apr 20
Is Synthomer plc (LON:SYNT) Expensive For A Reason? A Look At Its Intrinsic Value

Even With A 45% Surge, Cautious Investors Are Not Rewarding Synthomer plc's (LON:SYNT) Performance Completely

Mar 14
Even With A 45% Surge, Cautious Investors Are Not Rewarding Synthomer plc's (LON:SYNT) Performance Completely

Should You Think About Buying Synthomer plc (LON:SYNT) Now?

Feb 08
Should You Think About Buying Synthomer plc (LON:SYNT) Now?

Is Now An Opportune Moment To Examine Synthomer plc (LON:SYNT)?

Oct 17
Is Now An Opportune Moment To Examine Synthomer plc (LON:SYNT)?

Here's Why Synthomer (LON:SYNT) Is Weighed Down By Its Debt Load

Sep 12
Here's Why Synthomer (LON:SYNT) Is Weighed Down By Its Debt Load

Synthomer plc's (LON:SYNT) Intrinsic Value Is Potentially 87% Above Its Share Price

Aug 17
Synthomer plc's (LON:SYNT) Intrinsic Value Is Potentially 87% Above Its Share Price

Is Synthomer plc (LON:SYNT) Potentially Undervalued?

Jun 21
Is Synthomer plc (LON:SYNT) Potentially Undervalued?

Here's Why Synthomer (LON:SYNT) Is Weighed Down By Its Debt Load

May 27
Here's Why Synthomer (LON:SYNT) Is Weighed Down By Its Debt Load

Is There Now An Opportunity In Synthomer plc (LON:SYNT)?

Dec 19
Is There Now An Opportunity In Synthomer plc (LON:SYNT)?

Financial Position Analysis

Short Term Liabilities: SYNT's short term assets (£833.7M) exceed its short term liabilities (£509.0M).

Long Term Liabilities: SYNT's short term assets (£833.7M) do not cover its long term liabilities (£946.1M).


Debt to Equity History and Analysis

Debt Level: SYNT's net debt to equity ratio (64%) is considered high.

Reducing Debt: SYNT's debt to equity ratio has reduced from 118.5% to 90.8% over the past 5 years.

Debt Coverage: SYNT's debt is not well covered by operating cash flow (1.6%).

Interest Coverage: Insufficient data to determine if SYNT's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/07 18:06
End of Day Share Price 2025/10/07 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Synthomer plc is covered by 24 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert BateBarclays
Katie RichardsBarclays
James StewartBarclays